Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD28-B7 interactions in T-cell activation

J P Allison1

  • 1Department of Molecular and Cell Biology, University of California, Berkeley 94720.

Current Opinion in Immunology
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

Science (New York, N.Y.)·2017
Same author

The T-cell antigen receptor gamma gene: rearrangement and cell lineages.

Immunology today·2014
Same author

Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer.

Gene therapy·2014
Same author

Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists.

Clinical and experimental immunology·2009
Same author

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses.

The Journal of experimental medicine·2001
Same author

Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy.

The Journal of experimental medicine·2001
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

Optimal T-cell activation relies on co-stimulatory signals, primarily CD28, interacting with B7 ligands. This complex interplay regulates immune responses and offers new therapeutic strategies.

Area of Science:

  • Immunology
  • Cellular Biology
  • Molecular Medicine

Background:

  • Optimal T-cell activation necessitates co-stimulatory signals beyond antigen receptor engagement.
  • CD28 is identified as the principal co-stimulatory receptor on T cells.
  • B7 serves as the natural ligand for CD28 on antigen-presenting cells.

Purpose of the Study:

  • To elucidate the critical role of CD28-mediated co-stimulation in T-cell activation.
  • To explore the diversity of B7 ligands and their expression patterns.
  • To understand the dynamic interplay of co-stimulatory molecules in immune regulation.

Main Methods:

  • Review and synthesis of recent immunological research.
  • Analysis of T-cell subset activation pathways.

Related Experiment Videos

  • Investigation of ligand-receptor interactions in antigen presentation.

    • Main Results:

    • CD28 co-stimulation is crucial for nearly all T-cell subsets.
    • Multiple B7 ligands exist and are differentially expressed on antigen-presenting cells.
    • A complex, dynamic interaction between T-cell and antigen-presenting cell molecules regulates activation.

    Conclusions:

    • CD28-B7 interactions are fundamental to T-cell activation across various subsets.
    • The diversity of ligands adds complexity to immune response regulation.
    • Understanding these interactions provides avenues for manipulating immune responses in vivo.